Price target
48.650.000.00%
The 7 analysts offering 1-year price forecasts have a max estimate of — and a min estimate of —.
Analyst rating
Based on 8 analysts giving stock ratings in the past 3 months.
EPS
Reported
Estimate
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
1AKRO EPS for the last quarter is −0.84 EUR despite the estimation of −0.82 EUR. In the next quarter EPS is expected to reach −0.87 EUR. Track more of Akero Therapeutics, Inc. financials and stay on top of what is up with the company.
In the next quarter Akero Therapeutics, Inc. revenue is expected to reach 0.00 EUR. Check out Akero Therapeutics, Inc. revenue and earnings and make informed decisions.
According to analysts, 1AKRO price target is 48.65 EUR with a max estimate of 51.86 EUR and a min estimate of 46.67 EUR. Check if this forecast comes true in a year, meanwhile watch Akero Therapeutics, Inc. stock price chart and keep track of the current situation with 1AKRO news and stock market news.
We've gathered opinions of 8 analysts rating 1AKRO stock in the past 3 months. Most of them backed up the neutral trend, and after taking into account other opinions, the overall rating was calculated as neutral. Note that it's not a trading advice — your own analysis is still required.